WelcomeUser Guide
ToSPrivacyCanary
DonateBugsLicense

©2026 Poal.co

264

I'm laughing all the way to the no-shot bank.

The extent to which severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants of concern (VOC) break through infection- or vaccine-induced immunity is not well understood. Here, we analyze 28,578 sequenced SARS-CoV-2 samples from individuals with known immune status obtained through national community testing in the Netherlands from March to August 2021. We find evidence for an increased risk of infection by the Beta (B.1.351), Gamma (P.1), or Delta (B.1.617.2) variants compared to the Alpha (B.1.1.7) variant after vaccination. No clear differences were found between vaccines. However, the effect was larger in the first 14-59 days after complete vaccination compared to 60 days and longer. In contrast to vaccine-induced immunity, no increased risk for reinfection with Beta, Gamma or Delta variants relative to Alpha variant was found in individuals with infection-induced immunity.

In contrast to vaccine-induced immunity, no increased risk for reinfection with Beta, Gamma or Delta variants relative to Alpha variant was found in individuals with infection-induced immunity.

Here's a comment from communities.win that talks about the paper:

This hasn't passed peer review (and even that isn't the vaunted gold standard for study credibility) so take it with a preliminary grain of salt. But it largely tracks with evidence from other studies and trends - the first couple months post-vaccination appears to increase infectivity amongst those with the jab, with the vulnerability falling off for the next few months. This is true across all the vaccines on market. You're practically creating new cases with every forced surge of boosters. I know people have been ringing the ADE alarm for a long time but the trends are starting to come into focus. Will be interesting to follow, at least.

I'm laughing all the way to the no-shot bank. > The extent to which severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants of concern (VOC) break through infection- or vaccine-induced immunity is not well understood. Here, we analyze 28,578 sequenced SARS-CoV-2 samples from individuals with known immune status obtained through national community testing in the Netherlands from March to August 2021. We find evidence for an increased risk of infection by the Beta (B.1.351), Gamma (P.1), or Delta (B.1.617.2) variants compared to the Alpha (B.1.1.7) variant after vaccination. No clear differences were found between vaccines. However, the effect was larger in the first 14-59 days after complete vaccination compared to 60 days and longer. In contrast to vaccine-induced immunity, no increased risk for reinfection with Beta, Gamma or Delta variants relative to Alpha variant was found in individuals with infection-induced immunity. # In contrast to vaccine-induced immunity, no increased risk for reinfection with Beta, Gamma or Delta variants relative to Alpha variant was found in individuals with infection-induced immunity. Here's a comment from communities.win that talks about the paper: > This hasn't passed peer review (and even that isn't the vaunted gold standard for study credibility) so take it with a preliminary grain of salt. But it largely tracks with evidence from other studies and trends - the first couple months post-vaccination appears to increase infectivity amongst those with the jab, with the vulnerability falling off for the next few months. This is true across all the vaccines on market. You're practically creating new cases with every forced surge of boosters. I know people have been ringing the ADE alarm for a long time but the trends are starting to come into focus. Will be interesting to follow, at least.

(post is archived)

[–] 1 pt

But the trusted news sources didn't say it so it isn't true.

This has been debunked by some random person on the internet on a trusted debunking source and some random person on Facebook flagged it as fake news.

~The average moron.